A Study to Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis

Nagoya City University Hospital, Nagoya

Juntendo Univ Urayasu Hosp, Urayasu Shi

Takagi Dermatological Clinic, Obihiro

Mie University Hospital, Tsu

Kansai Medical University Hospital, Hirakata-shi

Shizuoka General Hospital, Shizuoka

Tokyo Medical University Hosp, Shinjuku-ku

Fukuoka University Hospital, Fukuoka

The University of Tokyo Hosp, Tokyo